Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) saw a large decline in short interest in April. As of April 30th, there was short interest totaling 662,171 shares, a decline of 36.9% from the April 15th total of 1,049,759 shares. Based on an average trading volume of 26,002 shares, the short-interest ratio is currently 25.5 days.
Roche Trading Up 2.8%
OTCMKTS RHHVF traded up $11.44 on Monday, hitting $418.60. 4,422 shares of the stock were exchanged, compared to its average volume of 20,067. Roche has a fifty-two week low of $300.15 and a fifty-two week high of $490.33. The company has a 50-day moving average price of $404.73 and a 200-day moving average price of $410.80.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Further Reading
- Five stocks we like better than Roche
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
